Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Governmental Funding And R&D Activities
3.1.2. Preference Of Multiplex Assays Over Conventional Assays
3.1.3. Adoption Of Personalized Medicines
3.2. Key Restraints
3.2.1. Unavailability Of Skilled Lab Technicians
3.2.2. Compliance With Strict Environmental Regulation

4. Key Analytics
4.1. Impact Of Covid-19 On Multiplex Assay Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Key Buying Criteria
4.5. Opportunity Matrix
4.6. Vendor Landscape

5. Market By Type
5.1. Protein-Based Multiplex Assay
5.2. Nucleic Acid-Based Multiplex Assay
5.3. Other Multiplex Assays

6. Market By Product
6.1. Reagents And Consumables
6.2. Instruments And Accessories
6.3. Software And Services

7. Market By Technology
7.1. Multiplex Protein Microarray
7.2. Multiplex Pcr
7.3. Other Technologies

8. Market By Application
8.1. Clinical Diagnostics
8.2. Research And Development
8.3. Companion Diagnostics

9. Market By End-User
9.1. Hospitals
9.2. Clinical Laboratories
9.3. Research Institutes
9.4. Pharmaceutical & Biotechnology Companies

10. Geographical Analysis
10.1. North America
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. United States
10.1.5.2. Canada

11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships & Agreements
11.1.4. Business Expansions, Announcements, And Divestitures
11.2. Company Profiles
11.2.1. Abcam
11.2.2. Agilent Technologies Inc
11.2.3. Becton, Dickinson And Company (Bd)
11.2.4. Bio-Rad Laboratories Inc
11.2.5. Bio-Techne Corporation
11.2.6. F. Hoffmann-La Roche
11.2.7. Illumina Inc
11.2.8. Luminex Corporation
11.2.9. Merck Millipore
11.2.10. Olink Proteomics Ab
11.2.11. Qiagen Nv
11.2.12. Randox Laboratories Ltd
11.2.13. Seegene Inc
11.2.14. Siemens Healthineers Ag
11.2.15. Thermo Fisher Scientific Inc



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Multiplex Assay Market, By Type, In 2020
Figure 6: North America Multiplex Assay Market, By Protein-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 7: North America Multiplex Assay Market, By Nucleic Acid-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 8: North America Multiplex Assay Market, By Other Multiplex Assays, 2021-2028 (In $ Million)
Figure 9: North America Multiplex Assay Market, By Product, In 2020
Figure 10: North America Multiplex Assay Market, By Reagents And Consumables, 2021-2028 (In $ Million)
Figure 11: North America Multiplex Assay Market, By Instruments And Accessories, 2021-2028 (In $ Million)
Figure 12: North America Multiplex Assay Market, By Software And Services, 2021-2028 (In $ Million)
Figure 13: North America Multiplex Assay Market, By Technology, In 2020
Figure 14: North America Multiplex Assay Market, By Multiplex Protein Microarray, 2021-2028 (In $ Million)
Figure 15: North America Multiplex Assay Market, By Multiplex Pcr, 2021-2028 (In $ Million)
Figure 16: Advantages Of Immunohistochemistry (Ihc)
Figure 17: North America Multiplex Assay Market, By Other Technologies, 2021-2028 (In $ Million)
Figure 18: North America Multiplex Assay Market, By Application, In 2020
Figure 19: North America Multiplex Assay Market, By Clinical Diagnostics, 2021-2028 (In $ Million)
Figure 20: North America Multiplex Assay Market, By Research And Development, 2021-2028 (In $ Million)
Figure 21: North America Multiplex Assay Market, By Companion Diagnostics, 2021-2028 (In $ Million)
Figure 22: North America Multiplex Assay Market, By End-User, In 2020
Figure 23: North America Multiplex Assay Market, By Hospitals, 2021-2028 (In $ Million)
Figure 24: North America Multiplex Assay Market, By Clinical Laboratories, 2021-2028 (In $ Million)
Figure 25: North America Multiplex Assay Market, By Research Institutes, 2021-2028 (In $ Million)
Figure 26: North America Multiplex Assay Market, By Pharmaceutical & Biotechnology Companies, 2021-2028 (In $ Million)
Figure 27: North America Multiplex Assay Market, Country Outlook, 2020 & 2028 (In %)
Figure 28: United States Multiplex Assay Market, 2021-2028 (In $ Million)
Figure 29: Canada Multiplex Assay Market, 2021-2028 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - MULTIPLEX ASSAY
TABLE 2: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: LEADING PLAYERS OPERATING IN THE NORTH AMERICA MULTIPLEX ASSAY MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES